Loading ...
Sorry, an error occurred while loading the content.

4785Fw: December HCV Advocate posted to website

Expand Messages
  • Ken & Pat @home
    Nov 30, 2000
    • 0 Attachment
      alley/Patricia

      ----- Original Message -----
      From: <sfhepcat@...>
      To: <alleypat@...>
      Sent: Thursday, November 30, 2000 11:25 AM
      Subject: December HCV Advocate posted to website


      > December 2000's Advocate: www.hcvadvocate.org
      >
      >
      > HCV Treatment Reaches the Next Level
      > Schering-Plough Reports Phase III Results at AASLD: 54% Sustained Response
      Rates for all Genotypes ;Healthwise: How the Hepatitis C Virus is
      Transmitted This simple question should warrant an equally simple response;
      Synopsis of Roche Pegasys Studies from the AASLD -
      > Combination Therapies with Pegasys - Data from 4 Weeks of Treatment;
      Improved Virologic Response Rates with Pegasys compared to Roferon-A
      (standard interferon) in Blacks; Improving Liver Health with Antiviral
      Therapy; HCV News Briefs
      > Interleukin-11 Study - Treating Low Platelet Levels; Does Hep C Cause
      Diabetes?
      > Herb dose, price can vary widely with brand
      >
      > Subscribe to Hepatitis Magazine - Help Support the Hepatitis C Support
      Project
      >
      > Advocate Staff Notes - Noted Canadian HCV Activist Joins Advocate Staff
      > Volunteer of The Year: Joe Shaw
      >
      > Thanks - Alan Franciscus
      >
      >
      >
      >
    • Show all 2 messages in this topic